Joseph B. Kirsner Professor of Medicine | Chief, Section of Gastroenterology, Hepatology and Nutrition | Director, Inflammatory Bowel Disease Center | University of Chicago Medicine, Chicago, Illinois, United States

David T. Rubin is the Joseph B. Kirsner Professor of Medicine, Professor of Pathology, Chief of the Section of Gastroenterology, Hepatology & Nutrition and Director of the Inflammatory Bowel Disease Center at the University of Chicago Medicine. He earned a medical degree with honors at The University of Chicago Pritzker School of Medicine where he also completed his residency in internal medicine and fellowships in gastroenterology and clinical medical ethics. He is associate faculty member at the MacLean Center for Clinical Medical Ethics, associate investigator at the University of Chicago Comprehensive Cancer Center and a member of the University of Chicago Committee on Clinical Pharmacology and Pharmacogenomics. He is the immediate past Chair of the National Scientific Advisory Committee of the Crohn’s & Colitis Foundation and current Chair of the International Organization for the Study of IBD.
Dr. Rubin’s research is focused on disease modification in IBD including clinical trial designs, novel measures of inflammation and prevention of adverse outcomes, and quality of life in IBD. He has twice received the ACG’s Governor’s Award of Excellence in Clinical Research (2003 and 2013), and in 2020, he received the Sherman Prize for Excellence in Crohn’s and Colitis. In 2023, Dr. Rubin received the UChicago Michael Reese Lectureship Award for outstanding faculty who have developed novel teaching and clinical research that advances healthcare, and separately, the distinguished UChicago Arthur H. Rubenstein Mentorship in Academic Medicine Award. He is Editor-in-Chief of the ACG On-Line Education Universe. Dr. Rubin is an editor of Curbside Consultation in IBD (3rd ed), senior editor of Sleisenger and Fordtran’s Gastrointestinal and Liver Disease (12th ed), and an author on >600 articles on management of IBD, including the 2019 and 2025 ACG Practice Guidelines for ulcerative colitis.